provaeducation.com Open in urlscan Pro
52.21.254.180  Public Scan

Form analysis
2 forms found in the DOM

GET /search/

<form class="js-search-input search-form hidden" method="get" action="/search/"><input class="search-form__input" type="text" name="q" value=""><input type="hidden" name="order_by" value="1"><input class="search-form__submit" value="" type="submit">
</form>

POST

<form class="share-module__form" action="" method="post"><input type="hidden" name="csrfmiddlewaretoken" value="zGWcEbRXYVklTaN5iUhdJbnUDEOKrfdVEwfr9leTiWu6APiZgQiQ6Cg7bazmurKm">
  <div class="field field-text"><select multiple="" data-autocomplete-light-function="select2" data-autocomplete-light-url="/messages/appuser-autocomplete/" id="id_recipient" name="recipient" placeholder="Peer's name" data-placeholder="Peer's name"
      tabindex="-1" class="select2-hidden-accessible" aria-hidden="true"></select><span class="select2 select2-container select2-container--default" dir="ltr" style="width: auto;"><span class="selection"><span
          class="select2-selection select2-selection--multiple" role="combobox" aria-haspopup="true" aria-expanded="false" tabindex="-1">
          <ul class="select2-selection__rendered">
            <li class="select2-search select2-search--inline"><input class="select2-search__field" type="search" tabindex="0" autocomplete="off" autocorrect="off" autocapitalize="off" spellcheck="false" role="textbox" aria-autocomplete="list"
                placeholder="Peer's name" style="width: 100px;"></li>
          </ul>
        </span></span><span class="dropdown-wrapper" aria-hidden="true"></span></span></div>
  <div class="field field-textarea"><textarea placeholder="Write your message"></textarea></div><button type="submit" class="btn-share">Share</button>
</form>

Text Content

Log InCreate an Account
LOG INCREATE AN ACCOUNT
 * HOME
 * News
   Business of MedicineGlobal HealthHealth PolicyHealth Technology
   
   Allergy, Asthma, and ImmunologyCardiologyDermatologyDiabetes and
   EndocrinologyEmergency MedicineGastroenterologyGeneticsGeriatrics
   
   Infectious DiseaseNephrologyNeurologyNutritionOB/GYN & Women's
   HealthOncologyOphthalmologyPain Management
   
   PediatricsPrimary CarePsychiatry and Mental HealthPulmonary
   MedicineRadiologyRheumatologySports MedicineSurgery
 * All Programs
   AudioAbstractsCME/CEClinical PracticeIndustry FeatureMedical InterestVideo
   Library
   
   Conference CoverageCystic Fibrosis in FocusDiabetes DiscourseFocus on
   AllergyFocus on CancerFocus on FibromyalgiaFocus on Neurology and Psychiatry
   
   Global Multiple Sclerosis AcademyGlobal Oncology AcademyGrand Rounds
   NationKeeping Pace in OncologyProva Oncology
 * Online Education
   Allergy and Clinical ImmunologyBladder Health/IncontinenceGeneral Medicine
   and Primary Care
   
   Oncology and HematologyPediatricsProva OncologyPulmonary MedicineWomen's
   HealthUrology
   
   Non-Certified & Non-Accredited
 * TOPICS
   Allergy and Clinical ImmunologyClinical PharmacologyDiabetes and
   EndocrinologyGeneral Medicine and Primary CareHIV/Aids and Infectious Disease
   
   Infectious DiseaseNeurology and NeurosurgeryNutritionOncology and
   HematologyPediatrics
   
   Poisoning and Drug ReferencePsychiatry and Mental HealthPulmonary
   MedicineRadiologyUrology
 * 





CHANGING THE PRACTICE OF MEDICINE

Discover CME, tools, and guideline-focused education to
improve your knowledge - and patient outcomes.





POPULAR

 *  * Mark Socinski, MD
      
      Peer
   
    * Jennifer Marie Suga, MD, MPH
      
      Peer
   
   0
   
   CME/CE
   
   RestartResume
   
   Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
   
   RestartResume
   
   Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
   
   0.25 credits
   
   Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
   
   0.25 credits

 *  * Shaji K. Kumar, MD
      
      Peer
   
    * María-Victoria Mateos, MD, PhD
      
      Peer
   
   0
   
   CME/CE
   
   RestartResume
   
   Multiple Myeloma: Updates from ASCO 2022
   
   RestartResume
   
   Multiple Myeloma: Updates from ASCO 2022
   
   0.25 credits
   
   Multiple Myeloma: Updates from ASCO 2022
   
   0.25 credits

 *  * Ian W. Flinn, MD, PhD
      
      Peer
   
    * William Wierda, MD
      
      Peer
   
   1
   
   CME/CE
   
   RestartResume
   
   Tackling Adverse Events Associated with Disruption of B-Cell Receptor
   Signaling: A Multispecialty Approach
   
   RestartResume
   
   Tackling Adverse Events Associated with Disruption of B-Cell Receptor
   Signaling: A Multispecialty Approach
   
   0.25 credits
   
   Tackling Adverse Events Associated with Disruption of B-Cell Receptor
   Signaling…
   
   0.25 credits

 *  * Amrita Krishnan, MD
      
      Peer
   
    * Morie Gertz, MD, MACP
      
      Peer
   
   2
   
   CME/CE
   
   RestartResume
   
   Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in
   Relapsed or Refractory Multiple Myeloma
   
   RestartResume
   
   Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in
   Relapsed or Refractory Multiple Myeloma
   
   0.25 credits
   
   Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in
   Rel…
   
   0.25 credits

 *  * Shaji K. Kumar, MD
      
      Peer
   
    * María-Victoria Mateos, MD, PhD
      
      Peer
   
   1
   
   CME/CE
   
   RestartResume
   
   Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
   
   RestartResume
   
   Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
   
   0.25 credits
   
   Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
   
   0.25 credits

 *  * Caitlin Costello, MD
      
      Peer
   
   0
   
   PROVA ONCOLOGY
   
   RestartResume
   
   Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
   
   RestartResume
   
   Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
   
   Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
   
   

 *  * Elizabeth Smyth, MD
      
      Peer
   
    * Jaffer Ajani, MD
      
      Peer
   
   4
   
   CME/CE
   
   RestartResume
   
   Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and
   GEJ Cancers
   
   RestartResume
   
   Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and
   GEJ Cancers
   
   0.25 credits
   
   Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and
   GE…
   
   0.25 credits
 * 

 *  * Rajendra Apte, MD, PhD
      
      Peer
   
    * Jennifer I. Lim, MD, FARVO
      
      Peer
   
    * Adrienne W. Scott, MD
      
      Peer
   
   0
   
   CME/CE
   
   RestartResume
   
   New Treatment Strategies for Diabetic Retinopathy: Sharpening the Focus
   
   RestartResume
   
   New Treatment Strategies for Diabetic Retinopathy: Sharpening the Focus
   
   0.25 credits
   
   New Treatment Strategies for Diabetic Retinopathy: Sharpening the Focus
   
   0.25 credits




CME/CE

 *  * Susan O’Brien, MD
      
      Peer
   
    * Timothy Call, MD
      
      Peer
   
   1
   
   CME/CE
   
   RestartResume
   
   State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
   
   RestartResume
   
   State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
   
   0.25 credits
   
   State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
   
   0.25 credits

 *  * Jacob D. Soumerai, MD
      
      Peer
   
    * Andrew H. Lipsky, MD
      
      Peer
   
   2
   
   CME/CE
   
   RestartResume
   
   Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
   
   RestartResume
   
   Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
   
   0.25 credits
   
   Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
   
   0.25 credits

 *  * Carolyn E. Majcher, OD, FAAO
      
      Peer
   
    * Diana Shechtman, OD, FAAO
      
      Peer
   
   1
   
   CME/CE
   
   RestartResume
   
   New Strategies for Managing Diabetic Retinopathy
   
   RestartResume
   
   New Strategies for Managing Diabetic Retinopathy
   
   0.25 credits
   
   New Strategies for Managing Diabetic Retinopathy
   
   0.25 credits

 *  * Richard Elion, MD
      
      Peer
   
   4
   
   CME/CE
   
   RestartResume
   
   Best Practices for Taking a Sexual History: Destigmatizing PrEP Care
   
   RestartResume
   
   Best Practices for Taking a Sexual History: Destigmatizing PrEP Care
   
   0.25 credits
   
   Best Practices for Taking a Sexual History: Destigmatizing PrEP Care
   
   0.25 credits

 *  * Lyudmila Bazhenova, MD
      
      Peer
   
    * Benjamin Levy, MD
      
      Peer
   
   7
   
   CME/CE
   
   RestartResume
   
   The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
   
   RestartResume
   
   The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
   
   0.25 credits
   
   The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
   
   0.25 credits

 *  * Richard S. Isaacson, MD
      
      Peer
   
    * Michael Weiner, MD
      
      Peer
   
   4
   
   CME/CE
   
   RestartResume
   
   Alzheimer’s Disease: Tools for Early Diagnosis
   
   RestartResume
   
   Alzheimer’s Disease: Tools for Early Diagnosis
   
   0.25 credits
   
   Alzheimer’s Disease: Tools for Early Diagnosis
   
   0.25 credits
 * 

SEE MORE



CLINICAL PRACTICE

 *  * Cesar Rodriquez Valdes, MD
      
      Peer
   
    * Amrita Krishnan, MD
      
      Peer
   
   3
   
   CME/CE
   
   RestartResume
   
   Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
   
   RestartResume
   
   Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
   
   0.25 credits
   
   Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
   
   0.25 credits

 *  * Andrew M. Brunner, MD
      
      Peer
   
    * Amy E. DeZern, MD, MHS
      
      Peer
   
   4
   
   CME/CE
   
   RestartResume
   
   A New Light in Higher-Risk MDS: Emerging Treatment Options
   
   RestartResume
   
   A New Light in Higher-Risk MDS: Emerging Treatment Options
   
   0.25 credits
   
   A New Light in Higher-Risk MDS: Emerging Treatment Options
   
   0.25 credits

 *  * Neal Bhatia, MD
      
      Peer
   
    * Jeffrey Sugarman, MD, PhD
      
      Peer
   
   2
   
   CME/CE
   
   RestartResume
   
   Rethinking the Use of Benzoyl Peroxide for Rosacea Treatment
   
   RestartResume
   
   Rethinking the Use of Benzoyl Peroxide for Rosacea Treatment
   
   0.25 credits
   
   Rethinking the Use of Benzoyl Peroxide for Rosacea Treatment
   
   0.25 credits

 *  * Peter K. Kaiser, MD
      
      Peer
   
   6
   
   CME/CE
   
   RestartResume
   
   Can You Classify This Patient’s Retinopathy?
   
   RestartResume
   
   Can You Classify This Patient’s Retinopathy?
   
   0.25 credits
   
   Can You Classify This Patient’s Retinopathy?
   
   0.25 credits

 *  * Neilanjan Nandi, MD
      
      Peer
   
    * Jean-Frederic Colombel, MD
      
      Peer
   
   2
   
   CME/CE
   
   RestartResume
   
   Emerging Therapies in UC
   
   RestartResume
   
   Emerging Therapies in UC
   
   0.25 credits
   
   Emerging Therapies in UC
   
   0.25 credits

 *  * Diana Do, MD
      
      Peer
   
    * John A. Wells, III, MD
      
      Peer
   
   2
   
   CME/CE
   
   RestartResume
   
   The Future Is Now: New Data for nAMD and DME in Vascular Integrity
   
   RestartResume
   
   The Future Is Now: New Data for nAMD and DME in Vascular Integrity
   
   0.25 credits
   
   The Future Is Now: New Data for nAMD and DME in Vascular Integrity
   
   0.25 credits
 * 

SEE MORE



PROGRAMS

 *  * Monique Hartley-Brown, MD, MMSc
      
      Peer
   
    * Shonali Midha, MD
      
      Peer
   
   1
   
   CME/CE
   
   RestartResume
   
   Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
   
   RestartResume
   
   Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
   
   0.25 credits
   
   Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
   
   0.25 credits

 *  * Susan B. Bressler, MD
      
      Peer
   
    * Mark Dunbar, OD, FAAO
      
      Peer
   
    * Ruth S. Weinstock, MD, PhD
      
      Peer
   
   1
   
   CME/CE
   
   RestartResume
   
   Saving Sight in Your Patients with Diabetes: What You Might Be Missing
   
   RestartResume
   
   Saving Sight in Your Patients with Diabetes: What You Might Be Missing
   
   0.25 credits
   
   Saving Sight in Your Patients with Diabetes: What You Might Be Missing
   
   0.25 credits

 *  * Sagar Lonial, MD
      
      Peer
   
    * Noopur Raje, MD
      
      Peer
   
   2
   
   CME/CE
   
   RestartResume
   
   Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
   
   RestartResume
   
   Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
   
   0.25 credits
   
   Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
   
   0.25 credits
 * 1
   
   OPHTHALMOLOGY
   
   RestartResume
   
   Staging of Nonproliferative Diabetic Retinopathy
   
   RestartResume
   
   Staging of Nonproliferative Diabetic Retinopathy
   
   Staging of Nonproliferative Diabetic Retinopathy
   
   

 *  * Hilary Baldwin, MD
      
      Peer
   
    * Linda Stein Gold, MD
      
      Peer
   
   1
   
   CME/CE
   
   RestartResume
   
   Update on the Benefits of a Microencapsulated Formulation of Benzoyl Peroxide
   and Tretinoin for Acne Treatment 
   
   RestartResume
   
   Update on the Benefits of a Microencapsulated Formulation of Benzoyl Peroxide
   and Tretinoin for Acne Treatment 
   
   0.25 credits
   
   Update on the Benefits of a Microencapsulated Formulation of Benzoyl Peroxide
   a…
   
   0.25 credits

 *  * Larry Anderson, MD, PhD
      
      Peer
   
    * Thomas G. Martin, MD
      
      Peer
   
   3
   
   CME/CE
   
   RestartResume
   
   State of the Union: CAR T Cell Therapy
   
   RestartResume
   
   State of the Union: CAR T Cell Therapy
   
   0.25 credits
   
   State of the Union: CAR T Cell Therapy
   
   0.25 credits
 * 

SEE MORE


TITLE

close

 * Terms
 * Privacy
 * About
 * Faculty
 * Contact
 * Cookies

--------------------------------------------------------------------------------

GET HELP(877) 776-8211


--------------------------------------------------------------------------------

500 Office Center Drive, Suite 300
Fort Washington, PA 19034

© All rights reserved.

This website is a member of the ReachMD Network.


SHARE ON REACHMD

Close
 * 


Share
 * Discussion
 * Player

LIVE ON REACHMD RADIOBack to live radio

ReachMD Radio

Loading...

addplayshare
00:00

00:00

show volume controller

 * On Air
 * Playlists



Register
close

We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free
You are now leaving Prova Education and going to a site run by another
organization.

Press cancel to remain on Prova Education. Press the link below or the continue
button to keep going.



CancelContinue



ABOUT YOUR PRIVACY

We process your data to deliver content or advertisements and measure the
delivery of such content or advertisements to extract insights about our
website. We share this information with our partners on the basis of consent and
legitimate interest. You may exercise your right to consent or object to a
legitimate interest, based on a specific purpose below or at a partner level in
the link under each purpose. These choices will be signaled to our vendors
participating in the Transparency and Consent Framework.
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active
Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

STORE AND/OR ACCESS INFORMATION ON A DEVICE

Store and/or access information on a device

Cookies, device identifiers, or other information can be stored or accessed on
your device for the purposes presented to you.

List of IAB Vendors‎ | View Full Legal Text Opens in a new Tab

PERSONALISED ADS AND CONTENT, AD AND CONTENT MEASUREMENT, AUDIENCE INSIGHTS AND
PRODUCT DEVELOPMENT

Personalised ads and content, ad and content measurement, audience insights and
product development

 * SELECT BASIC ADS
   
   Required Cookies
   
   Ads can be shown to you based on the content you’re viewing, the app you’re
   using, your approximate location, or your device type.
   
   Object to Legitimate Interests Remove Objection

 * CREATE A PERSONALISED ADS PROFILE
   
   Required Cookies
   
   A profile can be built about you and your interests to show you personalised
   ads that are relevant to you.
   
   Object to Legitimate Interests Remove Objection

 * SELECT PERSONALISED ADS
   
   Required Cookies
   
   Personalised ads can be shown to you based on a profile about you.
   
   Object to Legitimate Interests Remove Objection

 * CREATE A PERSONALISED CONTENT PROFILE
   
   Required Cookies
   
   A profile can be built about you and your interests to show you personalised
   content that is relevant to you.
   
   Object to Legitimate Interests Remove Objection

 * SELECT PERSONALISED CONTENT
   
   Required Cookies
   
   Personalised content can be shown to you based on a profile about you.
   
   Object to Legitimate Interests Remove Objection

 * MEASURE AD PERFORMANCE
   
   Required Cookies
   
   The performance and effectiveness of ads that you see or interact with can be
   measured.
   
   Object to Legitimate Interests Remove Objection

 * MEASURE CONTENT PERFORMANCE
   
   Required Cookies
   
   The performance and effectiveness of content that you see or interact with
   can be measured.
   
   Object to Legitimate Interests Remove Objection

 * APPLY MARKET RESEARCH TO GENERATE AUDIENCE INSIGHTS
   
   Required Cookies
   
   Market research can be used to learn more about the audiences who visit
   sites/apps and view ads.
   
   Object to Legitimate Interests Remove Objection

 * DEVELOP AND IMPROVE PRODUCTS
   
   Required Cookies
   
   Your data can be used to improve existing systems and software, and to
   develop new products
   
   Object to Legitimate Interests Remove Objection

List of IAB Vendors‎ | View Full Legal Text Opens in a new Tab

USE PRECISE GEOLOCATION DATA

Use precise geolocation data

Your precise geolocation data can be used in support of one or more purposes.
This means your location can be accurate to within several meters.

List of IAB Vendors‎ | View Full Legal Text Opens in a new Tab

ACTIVELY SCAN DEVICE CHARACTERISTICS FOR IDENTIFICATION

Actively scan device characteristics for identification

Your device can be identified based on a scan of your device's unique
combination of characteristics.

List of IAB Vendors‎ | View Full Legal Text Opens in a new Tab

ENSURE SECURITY, PREVENT FRAUD, AND DEBUG

Always Active
Ensure security, prevent fraud, and debug

Your data can be used to monitor for and prevent fraudulent activity, and ensure
systems and processes work properly and securely.

List of IAB Vendors‎ | View Full Legal Text Opens in a new Tab

TECHNICALLY DELIVER ADS OR CONTENT

Always Active
Technically deliver ads or content

Your device can receive and send information that allows you to see and interact
with ads and content.

List of IAB Vendors‎ | View Full Legal Text Opens in a new Tab

MATCH AND COMBINE OFFLINE DATA SOURCES

Always Active
Match and combine offline data sources

Data from offline data sources can be combined with your online activity in
support of one or more purposes

List of IAB Vendors‎ | View Full Legal Text Opens in a new Tab

LINK DIFFERENT DEVICES

Always Active
Link different devices

Different devices can be determined as belonging to you or your household in
support of one or more of purposes.

List of IAB Vendors‎ | View Full Legal Text Opens in a new Tab

RECEIVE AND USE AUTOMATICALLY-SENT DEVICE CHARACTERISTICS FOR IDENTIFICATION

Always Active
Receive and use automatically-sent device characteristics for identification

Your device might be distinguished from other devices based on information it
automatically sends, such as IP address or browser type.

List of IAB Vendors‎ | View Full Legal Text Opens in a new Tab
Confirm My Choices

Back Button

Back


PERFORMANCE COOKIES



Vendor Search Search Icon Filter Icon


Clear Filters

Information storage and access
Apply
Consent Leg.Interest

All Consent Allowed

Select All Vendors
Select All Vendors
All Consent Allowed

Confirm My Choices



WE CARE ABOUT YOUR PRIVACY

We and our partners store and/or access information on a device, such as unique
IDs in cookies to process personal data. You may accept or manage your choices
by clicking below, including your right to object where legitimate interest is
used, or at any time in the privacy policy page. These choices will be signaled
to our partners and will not affect browsing data.


WE AND OUR PARTNERS PROCESS DATA TO PROVIDE:

Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised ads
and content, ad and content measurement, audience insights and product
development. List of Partners (vendors)

I Accept Show Purposes


Help us improve by sharing your feedback.